Actavis signs agreement to buy Botox-maker Allergan for $66bn

Ireland-based pharmaceutical company Actavis has signed an agreement to acquire US-based Botox-maker Allergan for $66bn or $219 per share.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news